This inventor holds 2 USPTO granted patents. Top assignee: E. R. Squibb Sons, Inc.. Active years: 1988-1991.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1988-1991
Title: John R. Howard: Innovator in Pharmaceutical Compositions
Introduction
John R. Howard is a notable inventor based in Merseyside, GB. He has made significant contributions to the field of pharmaceuticals, particularly in the development of innovative drug formulations. With a total of 2 patents to his name, Howard's work focuses on enhancing the efficacy and delivery of pharmaceutical compositions.
Latest Patents
Howard's latest patents include a pharmaceutical composition that utilizes an extrusion-spheronization technique. This composition is designed to contain more than 80% by weight of the drug, along with specific non-lipophilic binder-plasticizers and starch-based excipients. The method aims to control water distribution and prevent agglomeration during processing. Additionally, he has developed a controlled release pharmaceutical formulation that releases a basic pharmaceutical at a consistent rate, regardless of the environmental pH. This formulation incorporates a pH-dependent polymer and a pH-independent hydrocarbon gelling agent, ensuring effective drug delivery.
Career Highlights
John R. Howard is currently employed at E. R. Squibb Sons, Inc., where he continues to innovate in the pharmaceutical sector. His work has been instrumental in advancing drug formulation techniques that improve patient outcomes.
Collaborations
Throughout his career, Howard has collaborated with esteemed colleagues such as Peter Timmins and Anne M. Delargy. These partnerships have fostered a collaborative environment that enhances the development of new pharmaceutical technologies.
Conclusion
John R. Howard's contributions to pharmaceutical innovations demonstrate his commitment to improving drug delivery systems. His patents reflect a deep understanding of the complexities involved in pharmaceutical compositions, making him a valuable asset to the industry.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
